These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 37465682)

  • 101. Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid Malignancies.
    Heftdal LD; Hansen CB; Hamm SR; Pérez-Alós L; Fogh K; Pries-Heje M; Hasselbalch RB; Møller DL; Gang AO; Ostrowski SR; Frikke-Schmidt R; Sørensen E; Hilsted L; Bundgaard H; Garred P; Iversen K; Sabin C; Nielsen SD; Grønbæk K
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38275946
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Induced humoral immunity of different types of vaccines against most common variants of SARS-CoV-2 in Egypt prior to Omicron outbreak.
    El-Shesheny R; El Taweel A; Gomaa MR; Roshdy WH; Kandeil A; Webby RJ; Kayali G; Ali MA
    Vaccine; 2022 Jul; 40(32):4303-4306. PubMed ID: 35697574
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Impact of Antenatal SARS-CoV-2 Exposure on SARS-CoV-2 Neutralization Potency.
    Chiang CJ; Hsu WL; Su MT; Ko WC; Hsu KF; Tsai PY
    Vaccines (Basel); 2024 Feb; 12(2):. PubMed ID: 38400147
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge.
    Guan X; Verma AK; Wang G; Shi J; Perlman S; Du L
    iScience; 2023 Oct; 26(10):108033. PubMed ID: 37822493
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2.
    Clairon Q; Prague M; Planas D; Bruel T; Hocqueloux L; Prazuck T; Schwartz O; Thiébaut R; Guedj J
    PLoS Comput Biol; 2023 Aug; 19(8):e1011282. PubMed ID: 37549192
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Efficient transplacental transfer of SARS-CoV-2 antibodies between naturally exposed mothers and infants in Accra, Ghana.
    Partey FD; Obiri D; Bonney EY; Pobee ANA; Damptey IK; Ennuson K; Akwetea-Foli J; Nuokpem FY; Courtin D; Kusi KA; Mensah BA
    Sci Rep; 2024 May; 14(1):10772. PubMed ID: 38730052
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against Omicron.
    Sieber J; Mayer M; Schmidthaler K; Kopanja S; Camp JV; Popovitsch A; Dwivedi V; Hoz J; Schoof A; Weseslindtner L; Szépfalusi Z; Stiasny K; Aberle JH
    Front Immunol; 2022; 13():882456. PubMed ID: 35663948
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction.
    Hayashi H; Sun J; Yanagida Y; Otera T; Tai JA; Nishikawa T; Yamashita K; Sakaguchi N; Yoshida S; Baba S; Chang CY; Shimamura M; Okamoto S; Amaishi Y; Chono H; Mineno J; Rakugi H; Morishita R; Nakagami H
    Sci Rep; 2023 Aug; 13(1):13033. PubMed ID: 37563266
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model.
    Kalnin KV; Plitnik T; Kishko M; Huang D; Raillard A; Piolat J; Anosova NG; Tibbitts T; DiNapoli J; Karve S; Goldman R; Gopani H; Dias A; Tran K; Zacharia M; Gu X; Boeglin L; Abysalh J; Vargas J; Beaulieu A; Shah M; Jeannotte T; Gillis K; Chivukula S; Swearingen R; Landolfi V; Fu TM; DeRosa F; Casimiro D
    Vaccine; 2022 Feb; 40(9):1289-1298. PubMed ID: 35101265
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women.
    Chayachinda C; Watananirun K; Phatihattakorn C; Anuwutnavin S; Niyomnaitham S; Phongsamart W; Lapphra K; Wittawatmongkol O; Rungmaitree S; Jansarikit L; Boonnak K; Wongprompitak P; Senawong S; Upadhya A; Toh ZQ; Licciardi PV; Chokephaibulkit K
    Hum Vaccin Immunother; 2023 Aug; 19(2):2228670. PubMed ID: 37439770
    [TBL] [Abstract][Full Text] [Related]  

  • 111. SARS-CoV-2 neutralizing antibody titers in maternal blood, umbilical cord blood, and breast milk.
    Khalifeh M; Rubin LG; Dayya D; Cerise J; Skinner K; Maloney M; Walworth C; Petropoulos CJ; Wrin T; Chun K; Weinberger B
    J Perinatol; 2024 Jan; 44(1):28-34. PubMed ID: 38092879
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination.
    Harthaller T; Falkensammer B; Bante D; Huber M; Schmitt M; Benainouna H; Rössler A; Fleischer V; von Laer D; Kimpel J; Würzner R; Borena W
    Front Immunol; 2023; 14():1196988. PubMed ID: 37545492
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Safety and efficacy of COVID-19 vaccine immunization during pregnancy in 1024 pregnant women infected with the SARS-CoV-2 Omicron virus in Shanghai, China.
    Deng H; Jin Y; Sheng M; Liu M; Shen J; Qian W; Zou G; Liao Y; Liu T; Ling Y; Fan X
    Front Immunol; 2023; 14():1303058. PubMed ID: 38292486
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up.
    Barda N; Lustig Y; Indenbaum V; Zibly D; Joseph G; Asraf K; Weiss-Ottolenghi Y; Amit S; Kliker L; Abd Elkader B; Ben-Ami E; Canetti M; Koren R; Katz-Likvornik S; Halpern O; Mendelson E; Doolman R; Harats D; Kreiss Y; Mandelboim M; Regev-Yochay G
    Clin Microbiol Infect; 2023 Jul; 29(7):918-923. PubMed ID: 36921715
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.
    Fendler A; Shepherd STC; Au L; Wu M; Harvey R; Wilkinson KA; Schmitt AM; Tippu Z; Shum B; Farag S; Rogiers A; Carlyle E; Edmonds K; Del Rosario L; Lingard K; Mangwende M; Holt L; Ahmod H; Korteweg J; Foley T; Barber T; Emslie-Henry A; Caulfield-Lynch N; Byrne F; Deng D; Kjaer S; Song OR; Queval CJ; Kavanagh C; Wall EC; Carr EJ; Caidan S; Gavrielides M; MacRae JI; Kelly G; Peat K; Kelly D; Murra A; Kelly K; O'Flaherty M; Shea RL; Gardner G; Murray D; Popat S; Yousaf N; Jhanji S; Tatham K; Cunningham D; Van As N; Young K; Furness AJS; Pickering L; Beale R; Swanton C; Gandhi S; Gamblin S; Bauer DLV; Kassiotis G; Howell M; Nicholson E; Walker S; Wilkinson RJ; Larkin J; Turajlic S
    Cell Rep Med; 2022 Oct; 3(10):100781. PubMed ID: 36240755
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic.
    Costanzo GAML; Deiana CM; Sanna G; Perra A; Campagna M; Ledda AG; Coghe F; Palmas V; Cappai R; Manzin A; Chessa L; Del Giacco S; Firinu D
    J Clin Immunol; 2023 Dec; 44(1):12. PubMed ID: 38129351
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine Model.
    Gattinger P; Kratzer B; Sehgal ANA; Ohradanova-Repic A; Gebetsberger L; Tajti G; Focke-Tejkl M; Schaar M; Fuhrmann V; Petrowitsch L; Keller W; Högler S; Stockinger H; Pickl WF; Valenta R
    Vaccines (Basel); 2024 Feb; 12(3):. PubMed ID: 38543863
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Restricted Omicron-specific cross-variant memory B-cell immunity after a 3rd dose/booster of monovalent Wuhan-Hu-1-containing COVID-19 mRNA vaccine.
    Haralambieva IH; Monroe JM; Ovsyannikova IG; Warner ND; Grill DE; Poland GA; Kennedy RB
    Vaccine; 2024 Feb; 42(4):912-917. PubMed ID: 38233288
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.
    Chang A; Akhtar A; Linderman SL; Lai L; Orellana-Noia VM; Valanparambil R; Ahmed H; Zarnitsyna VI; McCook-Veal AA; Switchenko JM; Koff JL; Blum KA; Ayers AA; O'Leary CB; Churnetski MC; Sulaiman S; Kives M; Sheng P; Davis CW; Nooka AK; Antia R; Dhodapkar MV; Suthar MS; Cohen JB; Ahmed R
    J Clin Oncol; 2022 Sep; 40(26):3020-3031. PubMed ID: 35436146
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Diverging Maternal and Cord Antibody Functions From SARS-CoV-2 Infection and Vaccination in Pregnancy.
    Adhikari EH; Lu P; Kang YJ; McDonald AR; Pruszynski JE; Bates TA; McBride SK; Trank-Greene M; Tafesse FG; Lu LL
    J Infect Dis; 2024 Feb; 229(2):462-472. PubMed ID: 37815524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.